Zydus Lifesciences' SEZ II unit clear USFDA inspection

Last Updated : Nov 05 2025 | 3:31 PM IST

Zydus Lifesciences announced that the USFDA conducted an inspection at the group's manufacturing plant located SEZ II, Ahmedabad, from 11th to 14th August 2025. The inspection was a Pre-Approval Inspection (PAI). The USFDA has concluded this inspection as closed.

The inspection concluded with NIL observations. The EIR has classified the facility as No Action Indicated (NAI).

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Connect with us on WhatsApp

Grasim Industries consolidated net profit rises 75.91% in the September 2025 quarter

Raymed Labs reports standalone net loss of Rs 0.01 crore in the September 2025 quarter

RMC Switchgears Q2 PAT rises 88% YoY to Rs 19 cr; revenue more than doubles on robust execution

Kaynes Tech's PAT more than doubles to Rs 121 crore; order book rises to Rs 8,099 crore

MIC Electronics approves fund raising via QIP and FCCBs

First Published: Nov 05 2025 | 2:44 PM IST